Company Will Increase Its Stake to 51 Percent After Finalizing Latest Agreement SALT LAKE CITY, UT - (HSMN NewsFeed) - Cancer Therapeutics, Inc. (OTC.BB:CTHP ), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer t…
Biopharmaceuticals, Oncology, Mergers & Acquisitions
Cancer Therapeutics Inc, NanoTherapies, calcium phosphate, nanoparticles

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Cancer Therapeutics Announces Letter of Intent With NanoTherapies, LLC”
Leave a Comment